E-Therapeutics stable as it pivots to drug discovery
e-Therapeutics
9.18p
09:14 30/04/24
0.00%
0.00p
Drug discovery company e-Therapeutics announced its full year results for the year to 31 January on Wednesday, with cash and deposits of £14.0m at year-end, down from £24.8m.
FTSE AIM All-Share
764.07
09:25 30/04/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,938.86
09:25 30/04/24
0.31%
70.73